These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 19179201)

  • 21. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study.
    Piccirillo G; Magrì D; Matera S; Magnanti M; Torrini A; Pasquazzi E; Schifano E; Velitti S; Marigliano V; Quaglione R; Barillà F
    Eur Heart J; 2007 Jun; 28(11):1344-50. PubMed ID: 17101636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial cardiac 123I-metaiodobenzylguanidine scintigraphic studies are more useful for predicting cardiac death than one-time scan in patients with chronic heart failure: sub-analysis of our previous report.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Nucl Med Commun; 2010 Sep; 31(9):807-13. PubMed ID: 20543756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
    Nagamatsu H; Momose M; Kobayashi H; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Nov; 21(9):513-20. PubMed ID: 18030583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Washout rate of cardiac iodine-123 metaiodobenzylguanidine is high in chronic heart failure patients with central sleep apnea.
    Tamura A; Ando S; Goto Y; Kawano Y; Shinozaki K; Kotoku M; Kadota J
    J Card Fail; 2010 Sep; 16(9):728-33. PubMed ID: 20797596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of beat-to-beat QT variability index across the continuum of left ventricular dysfunction: competing risks of noncardiac or cardiovascular death and sudden or nonsudden cardiac death.
    Tereshchenko LG; Cygankiewicz I; McNitt S; Vazquez R; Bayes-Genis A; Han L; Sur S; Couderc JP; Berger RD; de Luna AB; Zareba W
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):719-27. PubMed ID: 22730411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
    Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M
    J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording.
    Soliman EZ; Elsalam MA; Li Y
    Europace; 2010 Feb; 12(2):261-5. PubMed ID: 19887457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
    Narita M; Kurihara T
    J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
    Ikeda-Yorifuji I; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Fukuhara E; Abe M; Nakamura J; Fukunami M
    J Nucl Cardiol; 2020 Jun; 27(3):992-1001. PubMed ID: 30761485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification of patients with chronic heart failure using cardiac iodine-123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction.
    Tamaki S; Yamada T; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Kawai T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    ESC Heart Fail; 2015 Dec; 2(4):116-121. PubMed ID: 27708857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic values of
    Hashimoto H; Nakanishi R; Mizumura S; Hashimoto Y; Okamura Y; Yamanaka K; Yamazaki J; Ikeda T
    J Nucl Cardiol; 2020 Jun; 27(3):833-842. PubMed ID: 30386980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
    Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART).
    Brooksby P; Batin PD; Nolan J; Lindsay SJ; Andrews R; Mullen M; Baig W; Flapan AD; Prescott RJ; Neilson JM; Cowley AJ; Fox KA
    Eur Heart J; 1999 Sep; 20(18):1335-41. PubMed ID: 10462468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.
    Nakata T; Wakabayashi T; Kyuma M; Takahashi T; Hashimoto A; Ogata H; Tsuchihashi K; Shimamoto K
    J Card Fail; 2003 Apr; 9(2):113-21. PubMed ID: 12751132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval.
    Genovesi S; Rossi E; Nava M; Riva H; De Franceschi S; Fabbrini P; Viganò MR; Pieruzzi F; Stella A; Valsecchi MG; Stramba-Badiale M
    Europace; 2013 Jul; 15(7):1025-33. PubMed ID: 23284142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodine-123 metaiodobenzylguanidine imaging can predict future cardiac events in Japanese patients with Parkinson's disease.
    Kinbara T; Hayano T; Otani N; Furutani Y; Tanaka S
    Ann Nucl Med; 2013 Feb; 27(2):123-31. PubMed ID: 23086545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
    Doi T; Nakata T; Yuda S; Hashimoto A
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.